D. E. Shaw & Co., Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,313,824
-81.7%
812,016
-59.6%
0.01%
-82.7%
Q2 2023$50,915,343
-31.0%
2,011,669
-12.2%
0.05%
-34.2%
Q1 2023$73,822,453
+198.7%
2,291,911
+71.2%
0.08%
+192.6%
Q4 2022$24,716,463
-37.7%
1,338,920
-8.9%
0.03%
-42.6%
Q3 2022$39,678,000
+251.1%
1,469,573
+79.7%
0.05%
+261.5%
Q2 2022$11,302,000
-31.5%
817,740
-3.4%
0.01%
-13.3%
Q1 2022$16,502,000
+93.0%
846,268
+61.5%
0.02%
+114.3%
Q4 2021$8,550,000
+3226.8%
523,918
+5570.1%
0.01%
Q3 2021$257,000
-82.0%
9,240
-80.8%
0.00%
-100.0%
Q2 2021$1,425,000
+463.2%
48,087
+438.3%
0.00%
Q4 2020$253,000
-68.1%
8,933
-71.7%
0.00%
-100.0%
Q3 2020$794,000
+193.0%
31,584
+184.3%
0.00%
Q2 2020$271,000
+48.9%
11,111
-9.7%
0.00%
Q1 2020$182,000
-35.2%
12,300
-43.3%
0.00%
Q2 2019$281,000
-40.1%
21,686
-27.1%
0.00%
-100.0%
Q1 2019$469,000
-76.8%
29,729
-70.4%
0.00%
-66.7%
Q4 2018$2,023,000
+24.9%
100,490
+54.1%
0.00%
+50.0%
Q3 2018$1,620,000
-24.3%
65,202
-16.4%
0.00%
-33.3%
Q2 2018$2,141,000
+648.6%
77,994
+739.7%
0.00%
Q1 2018$286,000
-81.9%
9,288
-79.0%
0.00%
-100.0%
Q4 2017$1,579,000
+611.3%
44,172
+312.2%
0.00%
Q4 2016$222,000
-76.7%
10,717
-80.4%
0.00%
-100.0%
Q1 2016$954,000
-82.5%
54,621
-65.8%
0.00%
-75.0%
Q4 2015$5,464,000
+622.8%
159,939
+529.7%
0.01%
+700.0%
Q3 2015$756,000
-43.4%
25,400
-39.2%
0.00%
-50.0%
Q2 2015$1,336,00041,7720.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders